ENDOMETRIOID ADENOCARCINOMA
Clinical trials for ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two drugs vs. one: new hope for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is for people whose endometrial (uterine) cancer has returned after treatment. It compares two different immunotherapy approaches to see which is better at controlling the cancer. One group gets a single immunotherapy drug (nivolumab), while the other gets a combinatio…
Matched conditions: ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major cancer trial tracks if surgery stops Cancer's return
Knowledge-focused Recruiting nowThis study aims to understand how often early-stage uterine cancer comes back after standard surgery that includes a sentinel lymph node biopsy. It will also track how often patients develop long-term leg swelling (lymphedema) as a side effect of this procedure. Researchers will …
Matched conditions: ENDOMETRIOID ADENOCARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC